Healio September 5, 2018
Geisinger, a health system that serves more than 3 million residents throughout the eastern half of Pennsylvania and southern New Jersey, made medical history in the United States when it started routine DNA screening in July.
Since then, about 50 patients have had their blood drawn to see if they have any gene variations that cause disease to give them a head start on deciding how to manage their care, a Geisinger spokesperson told Healio Family Medicine. Screenings will cover heart disease and early-stage cancers, but not diseases considered nonactionable.
Today's Sponsors
Today's Sponsor